Importance of Quality of Life When Choosing Therapy for nmCRPC
A brief discussion on the role of quality of life in selecting best therapy for patients with non-metastatic castration-resistant prostate cancer.
Source: onclive.com
Aramis Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Aramis Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Aramis Study Today - Breaking & Trending Today
AR Inhibitors in nmCRPC: Real-World Data
Key opinion leaders reflect on the real-world use and data behind AR inhibitors in non-metastatic castration-resistant prostate cancer.
Source: onclive.com
nmCRPC: Clinical Trial Data on AR Inhibitors
Shared insight on the SPARTAN, PROSPER, and ARAMIS studies with androgen receptor (AR) inhibitors in non-metastatic castration-resistant prostate cancer.
Source: onclive.com